These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9263168)

  • 1. The continuing challenge of predictive factors in rheumatoid arthritis.
    Coste J; Paolaggi JB
    J Rheumatol; 1997 Aug; 24(8):1653-4. PubMed ID: 9263168
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
    Niewold TB; Harrison MJ; Paget SA
    QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.
    Russell AS; Devani A; Maksymowych WP
    J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association?
    van der Heijde DM
    J Rheumatol; 1997 Jan; 24(1):6-8. PubMed ID: 9002003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rheumatoid arthritis, someday a disease with predictible progression?].
    Fardellone P
    Soins; 2004 Sep; (688):47. PubMed ID: 15515854
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical relevance of a prediction rule for disease outcome in patients with undifferentiated arthritis: comment on the article by van der Helm-van Mil et al.
    Visser H; Hazes JM; Luime J
    Arthritis Rheum; 2009 Jul; 60(7):2208-9; author reply 2209-10. PubMed ID: 19565508
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early 'Rheumatoid' arthritis cohorts: limited by selection.
    Inanc M
    Rheumatology (Oxford); 2007 Feb; 46(2):185-7. PubMed ID: 17043049
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease.
    McQueen FM; Benton N; Crabbe J; Robinson E; Yeoman S; McLean L; Stewart N
    Ann Rheum Dis; 2001 Sep; 60(9):859-68. PubMed ID: 11502613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An update on diagnostic and prognostic biomarkers of early rheumatoid arthritis].
    Senolt L
    Cas Lek Cesk; 2006; 145(7):538-42; discussion 542-3. PubMed ID: 16921781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a rheumatoid arthritis records-based index of severity.
    Ting G; Schneeweiss S; Katz JN; Weinblatt ME; Cabral D; Scranton RE; Solomon DH
    J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 13. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging outcomes and their role in determining outcomes in osteoarthritis and rheumatoid arthritis.
    Hunter DJ; Conaghan PG
    Curr Opin Rheumatol; 2006 Mar; 18(2):157-62. PubMed ID: 16462521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and prognosis of early arthritis: comment on the editorial by Scott.
    Visser H; Hazes JM
    Arthritis Rheum; 2003 Mar; 48(3):856-7; author reply 857-8. PubMed ID: 12632444
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural characterization of rheumatoid arthritis by MRI: applications in clinical research and in clinical practice.
    Peterfy C
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):360-1. PubMed ID: 15758259
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive and potentially predictive factors in early arthritis: a multidisciplinary approach.
    Härle P; Bongartz T; Schölmerich J; Müller-Ladner U; Straub RH
    Rheumatology (Oxford); 2005 Apr; 44(4):426-33. PubMed ID: 15716320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.